SARISOL NO. 2 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sarisol No. 2, and what generic alternatives are available?
Sarisol No. 2 is a drug marketed by Halsey and is included in one NDA.
The generic ingredient in SARISOL NO. 2 is butabarbital sodium. There are nine drug master file entries for this compound. Additional details are available on the butabarbital sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SARISOL NO. 2?
- What are the global sales for SARISOL NO. 2?
- What is Average Wholesale Price for SARISOL NO. 2?
Summary for SARISOL NO. 2
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Patent Applications: | 296 |
| DailyMed Link: | SARISOL NO. 2 at DailyMed |
US Patents and Regulatory Information for SARISOL NO. 2
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Halsey | SARISOL NO. 2 | butabarbital sodium | TABLET;ORAL | 084719-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
